Global Adult Vaccines Supply, Demand and Key Producers, 2023-2029

Global Adult Vaccines Supply, Demand and Key Producers, 2023-2029

The global Adult Vaccines market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Adult Vaccines production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Adult Vaccines, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Adult Vaccines that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Adult Vaccines total production and demand, 2018-2029, (K Units)

Global Adult Vaccines total production value, 2018-2029, (USD Million)

Global Adult Vaccines production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Adult Vaccines consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Adult Vaccines domestic production, consumption, key domestic manufacturers and share

Global Adult Vaccines production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Adult Vaccines production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Adult Vaccines production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Adult Vaccines market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Solvay Pharmaceuticals, Moderna, BioCSL (Seqirus), Aventis Pasteur, Sanofi Pasteur, Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline Plc and Novartis AG, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Adult Vaccines market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Adult Vaccines Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Adult Vaccines Market, Segmentation by Type
Monovalent Vaccines
Multivalent Vaccines

Global Adult Vaccines Market, Segmentation by Application
Private Healthcare Firms
Government Hospitals

Companies Profiled:
Solvay Pharmaceuticals
Moderna
BioCSL (Seqirus)
Aventis Pasteur
Sanofi Pasteur
Pfizer Inc.
Merck & Co. Inc.
GlaxoSmithKline Plc
Novartis AG
Johnson & Johnson
BioNTech
Bharat Biotech International Limited
Zhifei
Wyeth Vaccines
AstraZeneca Plc
Medimmune
Sinovac
Baxter International Healthcare Company
Chiron Vaccines
Serum Institute of India.

Key Questions Answered

1. How big is the global Adult Vaccines market?

2. What is the demand of the global Adult Vaccines market?

3. What is the year over year growth of the global Adult Vaccines market?

4. What is the production and production value of the global Adult Vaccines market?

5. Who are the key producers in the global Adult Vaccines market?